Critical Therapeutics, Inc. (CRTX) Reports Financial Results for the Third Quarter Ended September 30, 2008  
10/21/2008 10:28:01 AM

LEXINGTON, Mass.--(BUSINESS WIRE)--Critical Therapeutics, Inc. (NASDAQ: CRTX), a biopharmaceutical company focused on developing and commercializing innovative products for respiratory and inflammatory diseases, today reported financial results for the third quarter ended September 30, 2008.